Arthrex appeals Smith & Nephew patent loss; CytoSorbents teams with Biocon;

@FierceMedDev: Foundation Medicine eyes $92M in IPO. ICYMI Friday | Follow @FierceMedDev

@DamianFierce: Columbia Labs is buying into the CRO biz for $25M, grabbing Molecular Profiles. More from FierceCRO | Follow @DamianFierce

@MarkHFierce: Touch may help prevent hacking of insulin pumps and other wireless, implanted devices. Article via MIT Technology Review. | Follow @MarkHFierce

@MichaelGFierce: Delcath's chemo delivery device suffers FDA rejection. ICYMI from FierceDrugDelivery | Follow @MichaelGFierce

> Arthrex wants the U.S. Supreme Court to hear an appeal of its $85 million patent infringement loss to Smith & Nephew ($SNN). Story

> Corindus Vascular Robotics has started a study testing the safety and effectiveness of robotic angioplasty procedures. Item

> Stent developer InspireMD brought on a new head of global marketing and strategy. Item

> CytoSorbents will link with Biocon to bring its blood purification device to India. Story

Biotech News

@FierceBiotech: Veeva, provider of sales software to Merck, seeks up to $150M in IPO. Story from FierceBiotech IT | Follow @FierceBiotech

@JohnCFierce: ICYMI: ViroPharma shares soar on report of possible buyout offer. Article | Follow @JohnCFierce

@EmilyMFierce: Cheaper sequencing points cancer drug researchers to 'super responders.' More | Follow @EmilyMFierce

> Biosimilars developer Celltrion defends against allegations of insider trading. Report

> NovaBay shares jump on positive PhII catheter solution study. Item

> Chiesi values Cornerstone Therapeutics at $255M in buyout deal. Story

> FDA lifts hold on Pluristem's stem cell trial after tweaking protocol. News

Pharma News

@FiercePharma: GSK's happy: Arzerra won FDA breakthrough status; now, priority review for melanoma combo Tafinlar + Mekinist. Article | Follow @FiercePharma

@EricPFierce: GSK, Genmab get FDA 'breakthrough' designation for Arzerra in first-line use. ICYMI Friday | Follow @EricPFierce

@CarlyHFierce: Check out the new report by @EricPFierce: Top 10 rheumatoid arthritis drugs 2013. Feature | Follow @CarlyHFierce

> Roche lands Lufthansa CEO to take over chairman's job. News

> New Ranbaxy import ban provides Novartis with unexpected benefit. Story

> Viehbacher: Sanofi's options include buying back stake from L'Oreal, upping stake in Regeneron. Article

CRO News

> Harlan ups its European presence. Item

> Theorem teams with Charles River on preclinical work. Report

> Indian CRO TCG teams with Debiopharm for antibiotics. More

> Bayer taps DKSH with eye on Singapore. Story

> Italy's CROS NT reaches into U.S. with Stat-Tech buyout. Article

Biotech IT News

> TranSMART releases new version of research software from Johnson & Johnson. Item

> Qlucore corrals EU funding for hepatitis C software. Report

> AstraZeneca supports iPhone app for helping patients with heart disease. Article

> MIT center grabs $25M grant to build human-like computers. More

> Treato releases latest software: not another social media-listening app for pharma? Story

Suggested Articles

The randomized, blinded study showed statistically significant improvements in assessments of inattention and brain activity.

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.